{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:10:39Z","timestamp":1789996239790,"version":"4.0.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.humpath.2005.06.006","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T17:57:50Z","timestamp":1122659870000},"page":"861-870","source":"Crossref","is-referenced-by-count":141,"title":["Hereditary ovarian cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Jaime","family":"Prat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rib\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2005.06.006_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00004347-200101000-00005","article-title":"Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features","volume":"20","author":"Werness","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/beog.2002.0296","article-title":"The genetics of ovarian cancer","volume":"16","author":"Pharoah","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.humpath.2005.06.006_bib3","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","article-title":"Breast and ovarian cancer. Genomic medicine","volume":"348","author":"Wooster","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2005.06.006_bib4","series-title":"Ovarian cancer","first-page":"3","article-title":"Molecular genetics of hereditary ovarian cancer","author":"Boyd","year":"2001"},{"key":"10.1016\/j.humpath.2005.06.006_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0165-4608(96)00290-7","article-title":"An update of HNPCC (Lynch syndrome)","volume":"93","author":"Lynch","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2005.06.006_bib6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1006\/gyno.2002.6674","article-title":"Specific keynote: hereditary ovarian cancer: what we know","volume":"88","author":"Boyd","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib8","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2005.06.006_bib9","first-page":"3622","article-title":"Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer","volume":"56","author":"Foster","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2005.06.006_bib10","first-page":"2738","article-title":"Mutations of the BRCA2 gene in ovarian carcinomas","volume":"15","author":"Takahashi","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2005.06.006_bib11","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","article-title":"Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk","volume":"16","author":"Frank","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G","article-title":"Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations","volume":"16","author":"Khoo","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.humpath.2005.06.006_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.2002.6615","article-title":"Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study","volume":"85","author":"Reedy","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R","article-title":"Risk models for familial breast and ovarian cancer","volume":"18","author":"Antoniou","year":"2000","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.humpath.2005.06.006_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.humpath.2005.06.006_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2005.06.006_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","article-title":"The complete BRCA2 gene and mutations in chromosome 13q\u2013linked kindreds","volume":"12","author":"Tavtigian","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/35044000","article-title":"In search of the tumor suppressor functions of BRCA1 and BRCA2","volume":"408","author":"Scully","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2005.06.006_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(00)81847-4","article-title":"Association of BRCA1 with RAD51 in mitotic and meiotic cells","volume":"88","author":"Scully","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2005.06.006_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(92)90447-K","article-title":"RAD51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein","volume":"69","author":"Shinohara","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2005.06.006_bib21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","article-title":"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2005.06.006_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(00)80276-2","article-title":"Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells","volume":"2","author":"Chen","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2005.06.006_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jnci\/91.5.469","article-title":"Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations","volume":"91","author":"Philips","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2005.06.006_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/BC.1999.019","article-title":"The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins","volume":"380","author":"Irminger-Finger","year":"1999","journal-title":"Biol Chem"},{"key":"10.1016\/j.humpath.2005.06.006_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-9525(99)01930-7","article-title":"Insights into the functions of BRCA1 and BRCA2","volume":"16","author":"Welcsh","year":"2000","journal-title":"Trends Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/38291","article-title":"Arrest of the cell cycle by the tumor suppressor BRCA1 requires the CDK-inhibitor p21WAF1\/CiP1","volume":"389","author":"Somasundaram","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2005.06.006_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(00)80769-2","article-title":"Induction of GADD45 and JNK\/SAPK\u2013dependent apoptosis following inducible expression of BRCA1","volume":"97","author":"Harkin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2005.06.006_bib28","first-page":"455","article-title":"Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions","volume":"59","author":"Puget","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2005.06.006_bib29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/303076","article-title":"Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing","volume":"67","author":"Unger","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/humu.10108","article-title":"Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments","volume":"20","author":"Casilli","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.humpath.2005.06.006_bib31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/hmg\/ddg120","article-title":"Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast\/ovarian cancer families","volume":"12","author":"Montagna","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0009-9163.2004.00200.x","article-title":"Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families","volume":"65","author":"Barrois","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.ejhg.5201223","article-title":"Haplotype analysis of BRCA1 gene reveals a new gene rearrangement: characterization of a 19.9 KBP deletion","volume":"12","author":"Tancredi","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1095-198","article-title":"The carrier frequency of BRCA1 185delAG mutation is approximately 1% in Ashkenazi Jewish individuals","volume":"11","author":"Struewing","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng1096-188","article-title":"The carrier frequency of BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%","volume":"14","author":"Oddoux","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib37","first-page":"57","article-title":"Retinoblastoma: a prototypic hereditary neoplasm","volume":"5","author":"Knudson","year":"1978","journal-title":"Semin Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00004347-200004000-00009","article-title":"Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation","volume":"19","author":"Garc\u00eda","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/6029","article-title":"Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas","volume":"21","author":"Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation is a cause of BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Esteller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2005.06.006_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.1507","article-title":"Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene","volume":"202","author":"Wang","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1 mutations carriers","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2005.06.006_bib43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2005.06.006_bib44","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","article-title":"Pathology of ovarian cancers in BRCA1 and BRCA2 carriers","volume":"10","author":"Lakhani","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2005.06.006_bib45","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2005.06.006_bib46","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1086\/302853","article-title":"BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer","volume":"66","author":"Moslehi","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/ng0396-309","article-title":"Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeats (VNTR) locus","volume":"12","author":"Phelan","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib48","first-page":"908","article-title":"The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series","volume":"61","author":"Levine","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2005.06.006_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2005.06.006_bib50","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 and BRCA2 mutation: a case control study","volume":"57","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2005.06.006_bib51","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.bjc.6602239","article-title":"Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations","volume":"91","author":"Whittemore","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2005.06.006_bib52","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ijc.2910640608","article-title":"Risk modifiers in carriers of BRCA1 mutations","volume":"64","author":"Narod","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2005.06.006_bib53","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2005.06.006_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","article-title":"Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden","volume":"16","author":"Johannsson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9378(98)70632-5","article-title":"Clinical and genetic evaluation of thirty ovarian cancer families","volume":"178","author":"Zweemer","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2005.06.006_bib56","first-page":"868","article-title":"Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer","volume":"59","author":"Pharoah","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2005.06.006_bib57","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","article-title":"Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations","volume":"31","author":"Werness","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib58","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","article-title":"Characteristics of genetically determined ovarian cancer","volume":"21","author":"Shaw","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004347-199207000-00003","article-title":"Hereditary ovarian cancer","volume":"11","author":"Bewtra","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pgp.0000101083.35393.cd","article-title":"Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry","volume":"23","author":"Werness","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM199704173361602","article-title":"Contribution of BRCA1 mutations to ovarian cancer","volume":"336","author":"Stratton","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2005.06.006_bib62","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2005.06.006_bib63","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004347-200010000-00017","article-title":"Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation","volume":"19","author":"Werness","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1259\/0007-1285-40-474-459","article-title":"Ovarian dysgerminoma","volume":"40","author":"Jackson","year":"1967","journal-title":"Br J Radiol"},{"key":"10.1016\/j.humpath.2005.06.006_bib65","first-page":"137","article-title":"Dysgerminoma. Clinicopathological study of 22 cases","volume":"41","author":"Talerman","year":"1973","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2005.06.006_bib66","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/1097-0142(19940401)73:7<1980::AID-CNCR2820730732>3.0.CO;2-9","article-title":"Familial clustering of malignant germ cell tumors and Langerhans' histiocytosis","volume":"73","author":"Mandel","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2005.06.006_bib67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-8628(19990507)84:1<43::AID-AJMG9>3.0.CO;2-2","article-title":"Familial ovarian germ cell cancer: report and review","volume":"84","author":"Stettner","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib68","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2005.06.006_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0046-8177(99)90269-1","article-title":"Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer","volume":"30","author":"Werness","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib70","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.2000.5861","article-title":"Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds","volume":"78","author":"Casey","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2004","journal-title":"Int J Gynecol Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.humpath.2005.06.006_bib72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/ijgc-00009577-200409001-00499","article-title":"Prophylactic salpingo-oophorectomy in 51 women with familial ovarian-breast cancer: importance of fallopian tube dysplasia","volume":"14","author":"Leunen","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2005.06.006_bib73","first-page":"171","article-title":"Unexpected gynecological neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology and clinical follow-up","volume":"25","author":"Agoff","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004347-200304000-00001","article-title":"Challenges in the early diagnosis and staging of fallopian tube carcinomas associated with BRCA mutations","volume":"22","author":"Colgan","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2005.06.006_bib75","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2005.06.006_bib76","first-page":"585","article-title":"Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2005.06.006_bib77","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2005.06.006_bib78","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2005.06.006_bib79","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","article-title":"Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations","volume":"14","author":"Milne","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2005.06.006_bib80","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.273.6.491","article-title":"NIH Consensus Conference. Ovarian cancer. Screening, treatment, and follow-up","volume":"273","author":"NIH Consensus Development Panel on Ovarian Cancer","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2005.06.006_bib81","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with BRCA-1 or BRCA-2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl Med"},{"key":"10.1016\/j.humpath.2005.06.006_bib82","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA-1 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2005.06.006_bib83","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2004.06.090","article-title":"Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1\/2 mutations: a decision analysis","volume":"22","author":"Armstrong","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib84","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0029-7844(98)00223-3","article-title":"BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum","volume":"92","author":"Bandera","year":"1998","journal-title":"Obstet Gyneol"},{"key":"10.1016\/j.humpath.2005.06.006_bib85","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations","volume":"21","author":"Levine","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib86","first-page":"313","article-title":"BRCA2 germline mutations in primary cancer of the fallopian tube","volume":"12","author":"Casarsa","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2005.06.006_bib87","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib88","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1200\/JCO.2004.01.926","article-title":"Prophylactic oophorectomy and hormone replacement therapy: protection at what price?","volume":"22","author":"Garber","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib89","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/ejso.2000.1097","article-title":"Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations","volume":"27","author":"Ramus","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib90","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian carcinoma","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2005.06.006_bib91","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.20.2.463","article-title":"Effect of BRCA mutations on the length of survival in epithelial ovarian tumors","volume":"20","author":"David","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib92","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jnci\/91.3.259","article-title":"Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers","volume":"91","author":"Lee","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2005.06.006_bib93","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archinte.117.2.206","article-title":"Hereditary factors in cancer. Study of two large Midwestern kindreds","volume":"117","author":"Lynch","year":"1966","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.humpath.2005.06.006_bib94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.c.30026","article-title":"Inherited predisposition to cancer: a historical review","volume":"129C","author":"Lynch","year":"2004","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib95","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2005.06.006_bib96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gut.47.1.148","article-title":"DNA mismatch repair genes and colorectal cancer","volume":"47","author":"Wheeler","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2005.06.006_bib97","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.8484121","article-title":"Clues to the pathogenesis of familial colorectal cancer","volume":"260","author":"Aaltonen","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.humpath.2005.06.006_bib98","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/363558a0","article-title":"Ubiquitous somatic mutation in simple repeated sequences reveals a new mechanism for colonic carcinogenesis","volume":"363","author":"Ionov","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2005.06.006_bib99","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.8484122","article-title":"Microsatellite instability in cancer of the proximal colon","volume":"260","author":"Thibodeau","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.humpath.2005.06.006_bib100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","article-title":"DNA hypermethylation in tumorigenesis: epigenetics joins genetics","volume":"16","author":"Baylin","year":"2000","journal-title":"Trends Genet"},{"key":"10.1016\/j.humpath.2005.06.006_bib101","first-page":"5248","article-title":"National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination if microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2005.06.006_bib102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib103","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0090-8258(03)00371-8","article-title":"Gynecologic screening in hereditary nonpolyposis colorectal cancer","volume":"91","author":"Rijcken","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2005.06.006_bib104","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/gyno.2000.6065","article-title":"Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implication for gynecologic surveillance","volume":"80","author":"Brown","year":"2001","journal-title":"Gynecol Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817705002832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817705002832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T19:59:05Z","timestamp":1735847945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817705002832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":104,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0046817705002832"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2005.06.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}